Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Toxicon ; 70: 82-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23624384

ABSTRACT

This study presents the effects of two synthetic disulfide bond variants of cal16b, a 13-mer Ca²âº channel blocker conotoxin, on pro- and anti-inflammatory cytokine gene transcription in the murine macrophage-like cell line J774A.1 stimulated with LPS. The globular form (cal16b_1) acted as an anti-inflammatory agent; in contrast, the ribbon disulfide variant (cal16b_2) had a pro-inflammatory effect. Our results suggest that the pro- and anti-inflammatory effects are mediated by the three-dimensional structure.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Conotoxins/pharmacology , Conus Snail/chemistry , Cytokines/metabolism , Disulfides/pharmacology , Animals , Cell Line , Gene Expression Regulation , Inflammation/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Lipopolysaccharides , Macrophages/drug effects , Macrophages/metabolism , Mice , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
2.
Mar Drugs ; 11(4): 1188-202, 2013 Apr 08.
Article in English | MEDLINE | ID: mdl-23567319

ABSTRACT

A novel peptide, RsXXIVA, was isolated from the venom duct of Conus regularis, a worm-hunting species collected in the Sea of Cortez, México. Its primary structure was determined by mass spectrometry and confirmed by automated Edman degradation. This conotoxin contains 40 amino acids and exhibits a novel arrangement of eight cysteine residues (C-C-C-C-CC-CC). Surprisingly, two loops of the novel peptide are highly identical to the amino acids sequence of ω-MVIIA. The total length and disulfide pairing of both peptides are quite different, although the two most important residues for the described function of ω-MVIIA (Lys2 and Tyr13) are also present in the peptide reported here. Electrophysiological analysis using superior cervical ganglion (SCG) neurons indicates that RsXXIVA inhibits CaV2.2 channel current in a dose-dependent manner with an EC50 of 2.8 µM, whose effect is partially reversed after washing. Furthermore, RsXXIVA was tested in hot-plate assays to measure the potential anti-nociceptive effect to an acute thermal stimulus, showing an analgesic effect in acute thermal pain at 30 and 45 min post-injection. Also, the toxin shows an anti-nociceptive effect in a formalin chronic pain test. However, the low affinity for CaV2.2 suggests that the primary target of the peptide could be different from that of ω-MVIIA.


Subject(s)
Analgesics/pharmacology , Calcium Channel Blockers/pharmacology , Conotoxins/pharmacology , Conus Snail/chemistry , Acute Pain/drug therapy , Amino Acid Sequence , Analgesics/chemistry , Analgesics/isolation & purification , Animals , Calcium Channel Blockers/chemistry , Calcium Channel Blockers/isolation & purification , Calcium Channels, N-Type/drug effects , Calcium Channels, N-Type/metabolism , Chronic Pain/drug therapy , Conotoxins/chemistry , Conotoxins/isolation & purification , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Mass Spectrometry , Mexico , Mice , Mice, Inbred ICR , Peptides/chemistry , Peptides/isolation & purification , Peptides/pharmacology , Rats , Rats, Wistar , Superior Cervical Ganglion/drug effects , Superior Cervical Ganglion/metabolism , Time Factors
3.
MAbs ; 5(1): 80-5, 2013.
Article in English | MEDLINE | ID: mdl-23221782

ABSTRACT

The therapeutic use of single domain antibodies (sdAbs) is a promising new approach because these small antibodies maintain antigen recognition and neutralization capacity, have thermal and chemical stability and have good solubility. In this study, using phage display technology, we isolated a variable domain of a IgNAR (vNAR) from a Heterodontus francisci shark immunized against the recombinant human cytokine TNFα (rhTNFα). One clone T43, which expresses the vNAR protein in the periplasmic space, was isolated from the fourth round of panning. T43 had the capacity to recognize rhTNF and neutralize it in vitro, indicating that T43 has potential as a therapeutic that can be used for diseases in which this pro-inflammatory cytokine needs to be controlled.


Subject(s)
Antibodies, Neutralizing/immunology , Sharks/immunology , Single-Domain Antibodies/immunology , Tumor Necrosis Factor-alpha/immunology , Amino Acid Sequence , Animals , Antibodies, Neutralizing/biosynthesis , Antibodies, Neutralizing/chemistry , Antibodies, Neutralizing/therapeutic use , Antibody Specificity , Humans , Immunization , Immunoglobulin Variable Region/biosynthesis , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/immunology , Immunoglobulins/biosynthesis , Immunoglobulins/chemistry , Immunoglobulins/immunology , Male , Mice , Molecular Sequence Data , Neutralization Tests , Peptide Library , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Shock, Septic/immunology , Single-Domain Antibodies/biosynthesis , Single-Domain Antibodies/chemistry , Single-Domain Antibodies/therapeutic use , Tumor Necrosis Factor-alpha/genetics
4.
J Biol Chem ; 287(35): 29873-86, 2012 Aug 24.
Article in English | MEDLINE | ID: mdl-22782891

ABSTRACT

Ovarian cancer is the leading cause of death among gynecological malignancies. It is detected at late stages when the disease is spread through the abdominal cavity in a condition known as peritoneal carcinomatosis. Thus, there is an urgent need to develop novel therapeutic interventions to target advanced stages of ovarian cancer. Mammary serine protease inhibitor (Maspin) represents an important metastasis suppressor initially identified in breast cancer. Herein we have generated a sequence-specific zinc finger artificial transcription factor (ATF) to up-regulate the Maspin promoter in aggressive ovarian cancer cell lines and to interrogate the therapeutic potential of Maspin in ovarian cancer. We found that although Maspin was expressed in some primary ovarian tumors, the promoter was epigenetically silenced in cell lines derived from ascites. Transduction of the ATF in MOVCAR 5009 cells derived from ascitic cultures of a TgMISIIR-TAg mouse model of ovarian cancer resulted in tumor cell growth inhibition, impaired cell invasion, and severe disruption of actin cytoskeleton. Systemic delivery of lipid-protamine-RNA nanoparticles encapsulating a chemically modified ATF mRNA resulted in inhibition of ovarian cancer cell growth in nude mice accompanied with Maspin re-expression in the treated tumors. Gene expression microarrays of ATF-transduced cells revealed an exceptional specificity for the Maspin promoter. These analyses identified novel targets co-regulated with Maspin in human short-term cultures derived from ascites, such as TSPAN12, that could mediate the anti-metastatic phenotype of the ATF. Our work outlined the first targeted, non-viral delivery of ATFs into tumors with potential clinical applications for metastatic ovarian cancers.


Subject(s)
Gene Expression Regulation, Neoplastic , Neoplasms, Experimental/metabolism , Ovarian Neoplasms/metabolism , Transcription Factors/biosynthesis , Zinc Fingers , Actin Cytoskeleton/genetics , Actin Cytoskeleton/metabolism , Animals , Cell Line, Tumor , Female , Mice , Mice, Transgenic , Neoplasm Invasiveness , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology , Neoplasms, Experimental/therapy , Oligonucleotide Array Sequence Analysis , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Messenger/pharmacology , Serpins/biosynthesis , Tetraspanins/genetics , Tetraspanins/metabolism , Transcription Factors/genetics , Transcriptome
5.
Hybridoma (Larchmt) ; 30(4): 323-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21851231

ABSTRACT

In addition to conventional antibodies, cartilaginous fish have evolved a distinctive type of immunoglobulin, designated as IgNAR, which lacks the light polypeptide chains and is composed entirely by heavy chains. IgNAR molecules can be manipulated by molecular engineering to produce the variable domain of a single heavy chain polypeptide (vNARs). These, together with the VHH camel domains, constitute the smallest naturally occurring domains able to recognize an antigen. Their special features, such as small size, long extended finger-like CDR3, and thermal and chemical stability, make them suitable candidates for biotechnological purposes. Here we describe the generation of two mouse monoclonal antibodies (MAbs), MAb 370-12 and MAb 533-10, that both specifically react with vNAR domains of the horn shark Heterodontus francisci. While the former recognizes a broad spectrum of recombinant vNAR proteins, the latter is more restricted. MAb 370-12 precipitated a single band from whole shark serum, which was identified as IgNAR by mass spectrometry. Additionally, we used MAb 370-12 to follow the IgNAR-mediated immune response of sharks during immunization protocols with two different antigens (complete cells and a synthethic peptide), thus corroborating that MAb 370-12 recognizes both isolated vNAR domains and whole IgNAR molecules. Both MAbs represent an affordable molecular, biochemical, and biotechnological tool in the field of shark single-domain antibodies.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/genetics , Fish Proteins/genetics , Immunoglobulin Variable Region/genetics , Immunoglobulins/isolation & purification , Sharks/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal, Murine-Derived/immunology , Antibodies, Monoclonal, Murine-Derived/metabolism , Antibody Specificity , Cells, Cultured , Epitopes/chemistry , Erythrocytes/immunology , Fish Proteins/immunology , Fish Proteins/metabolism , Humans , Hybridomas/metabolism , Immunity, Humoral , Immunoglobulin Variable Region/immunology , Immunoglobulin Variable Region/metabolism , Immunoglobulins/genetics , Immunoglobulins/metabolism , Immunoprecipitation , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Binding , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Sharks/blood
6.
Toxicon ; 57(1): 60-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20920515

ABSTRACT

Conus californicus belongs to a genus of marine gastropods with more than 700 extant species. C. californicus has been shown to be distantly related to all Conus species, but showing unusual biological features. We report a novel peptide isolated from C. californicus with a significant inhibitory action over neuronal voltage-gated calcium channels. The new toxin is formed by 13-amino acid residues with two disulfide bonds, whose sequence (NCPAGCRSQGCCM) is strikingly different from regular ω-conotoxins. In the HPLC purification procedure, the venom fraction eluted in the first 10-15 min produced a significant decrease (54% ± 3%) of the Ca(2+) current in Xenopus laevis oocytes transfected with purified rat-brain mRNA. A specific peptide obtained from the elution at 13 min decreased the Ca(2+) current in the adult rat dorsal-root ganglion neurons in a primary culture by 34% ± 2%. The cysteine pattern of this peptide corresponds to the framework XVI described for the M-superfamily of conopeptides and is unprecedented among Conus peptides acting on Ca(2+) channels.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels, N-Type/metabolism , Conotoxins/pharmacology , Conus Snail , Mollusk Venoms/physiology , Neurons/drug effects , Amino Acid Sequence , Animals , Calcium Channel Blockers/chemistry , Calcium Channels, N-Type/physiology , Cells, Cultured , Chemical Fractionation , Chromatography, High Pressure Liquid , Conotoxins/chemistry , Electrophysiological Phenomena/drug effects , Electrophysiological Phenomena/physiology , Female , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Molecular Sequence Data , Mollusk Venoms/chemistry , Neurons/metabolism , Oocytes/drug effects , Oocytes/physiology , Patch-Clamp Techniques , Rats , Transfection , Xenopus laevis/physiology
7.
J Acquir Immune Defic Syndr ; 56(3): e70-4, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21124228

ABSTRACT

BACKGROUND: Similar to other resource-limited settings, cost restricts availability of viral load monitoring for most patients receiving antiretroviral therapy in Tijuana, Mexico. We evaluated if a pooling method could improve efficiency and reduce costs while maintaining accuracy. METHODS: We evaluated 700 patient blood plasma specimens at a reference laboratory in Tijuana for detectable viremia, individually and in 10 × 10 matrix pools. Thresholds for virologic failure were set at ≥500, ≥1000 and ≥1500 HIV RNA copies per milliliter. Detectable pools were deconvoluted using pre-set algorithms. Accuracy and efficiency of the pooling method were compared with individual testing. Quality assurance (QA) measures were evaluated after 1 matrix demonstrated low efficiency relative to individual testing. RESULTS: Twenty-two percent of the cohort had detectable HIV RNA (≥50 copies/mL). Pooling methods saved approximately one third of viral load assays over individual testing, while maintaining negative predictive values of >90% to detect samples with virologic failure (≥50 copies/mL). One matrix with low relative efficiency would have been detected earlier using the developed QA measures, but its exclusion would have only increased relative efficiency from 39% to 42%. These methods would have saved between $13,223 and $14,308 for monitoring this cohort. CONCLUSIONS: Despite limited clinical data, high prevalence of detectable viral loads and a contaminated matrix, pooling greatly improved efficiency of virologic monitoring while maintaining accuracy. By improving cost-effectiveness, these methods could provide sustainability of virologic monitoring in resource-limited settings, and incorporation of developed QA measures will most likely maximize pooling efficiency in future uses.


Subject(s)
Drug Monitoring/methods , HIV Infections/drug therapy , HIV Infections/virology , HIV/genetics , HIV/isolation & purification , Specimen Handling/methods , Viral Load/methods , Drug Monitoring/economics , Humans , Mexico , Plasma/virology , RNA, Viral/blood , Specimen Handling/economics , Treatment Failure , Viral Load/economics
8.
Med Microbiol Immunol ; 198(3): 157-74, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19529959

ABSTRACT

Antibodies are important tools for experimental research and medical applications. Most antibodies are composed of two heavy and two light chains. Both chains contribute to the antigen-binding site which is usually flat or concave. In addition to these conventional antibodies, llamas, other camelids, and sharks also produce antibodies composed only of heavy chains. The antigen-binding site of these unusual heavy chain antibodies (hcAbs) is formed only by a single domain, designated VHH in camelid hcAbs and VNAR in shark hcAbs. VHH and VNAR are easily produced as recombinant proteins, designated single domain antibodies (sdAbs) or nanobodies. The CDR3 region of these sdAbs possesses the extraordinary capacity to form long fingerlike extensions that can extend into cavities on antigens, e.g., the active site crevice of enzymes. Other advantageous features of nanobodies include their small size, high solubility, thermal stability, refolding capacity, and good tissue penetration in vivo. Here we review the results of several recent proof-of-principle studies that open the exciting perspective of using sdAbs for modulating immune functions and for targeting toxins and microbes.


Subject(s)
Antibodies/chemistry , Immunoglobulin Heavy Chains/chemistry , Amino Acid Sequence , Animals , Antibodies/immunology , Camelids, New World/immunology , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/immunology , Immunoglobulin Heavy Chains/immunology , Molecular Conformation , Molecular Sequence Data , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Sequence Alignment , Sharks/immunology
9.
Parasitol Int ; 58(3): 311-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19361571

ABSTRACT

PDI enzymes are oxidoreductases that catalyze oxidation, reduction and isomerization of disulfide bonds in polypeptide substrates. We have previously identified an E. histolytica PDI enzyme (EhPDI) that exhibits oxidase activity in vivo. However, little is known about the specific role of its redox-related structural features on the enzymatic activity. Here, we have studied the in vivo oxidative folding of EhPDI by mutagenic analysis and functional complementation assays as well as the in vitro oxidative folding and reductive activities by comparative kinetics using functional homologues in standard assays. We have found that the active-site cysteine residues of the functional domains (Trx-domains) are essential for catalysis of disulfide bond formation in polypeptides and proteins, such as the bacterial alkaline phosphatase. Furthermore, we have shown that the recombinant EhPDI enzyme has some typical properties of PDI enzymes: oxidase and reductase activities. These activities were comparable to those observed for other functional equivalents, such as bovine PDI or bacterial thioredoxin, under the same experimental conditions. These findings will be helpful for further studies intended to understand the physiological role of EhPDI.


Subject(s)
Entamoeba histolytica/enzymology , Protein Disulfide-Isomerases/chemistry , Protein Disulfide-Isomerases/metabolism , Protein Folding , Animals , Catalytic Domain , Entamoeba histolytica/genetics , Genetic Complementation Test , Mutation , Oxidation-Reduction , Protein Disulfide-Isomerases/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Structure-Activity Relationship
10.
Chemosphere ; 68(4): 662-70, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17397904

ABSTRACT

Nonylphenol is a metabolic intermediate from the microbial transformation of detergents used worldwide. While nonylphenol shows some acute toxicity, it is also able to mimic important hormones resulting in the disruption of several processes by interfering with the signals that control the overall physiology of the organism. The effect of the pollutant nonylphenol (NP) through the trophic chain was studied. Microalgae Isochrysis galbana was able to bioconcentrate NP 6940 times, where 77% of initial NP (100microgl(-1)) is accumulated intracellularly after 1-h incubation. Crustacean Artemia fransiscana showed 25% higher growth when fed with NP-rich algae. However, Artemia metabolized almost all NP ingested and only traces of NP could be found in the organism, eliminating future NP effects. Zebrafish (Brachydanio rerio) were affected by the presence of 171microgg(-1) of NP in the diet, showing higher levels of the hormone vitellogenin and lower levels of cytochrome P450 activity. These results showed that organisms placed in the first level of trophic chain are able to significantly bioconcentrate the pollutant and endocrine disruptor NP. These grassed organisms affect the growth of crustacean. Moreover, the organisms placed on the top of some trophic chains, such as fish, could be affected by the presence of NP in their food, in both the hormone levels and metabolic enzymes. This work shows that the environmental presence of NP should be considered as a risk for the organisms living in an ecosystem.


Subject(s)
Eukaryota/metabolism , Phenols/pharmacokinetics , Water Pollutants, Chemical/pharmacokinetics , Animals , Artemia/metabolism , Cytochrome P-450 CYP1A1/metabolism , Food Chain , Microsomes/enzymology , Oxygen/metabolism , Phenols/toxicity , Superoxide Dismutase/metabolism , Vitellogenins/metabolism , Water Pollutants, Chemical/toxicity , Zebrafish/metabolism
11.
Mol Pharmacol ; 67(4): 1034-44, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15615696

ABSTRACT

The physiological function of T lymphocytes can be modulated selectively by peptide toxins acting on Kv1.3 K(+) channels. Because Kv1.3-specific peptide toxins are considered to have a significant therapeutic potential in the treatment of autoimmune diseases, the discovery of new toxins is highly motivated. Through chromatographic procedures and electrophysiological assays, using patch-clamp methodology, the isolation of a novel peptide named anuroctoxin was accomplished using the venom of the Mexican scorpion Anuroctonus phaiodactylus. It has 35 amino acid residues with a molecular weight of 4082.8, tightly bound by four disulfide bridges whose complete covalent structure was determined. It has a pyroglutamic acid at the N-terminal region and an amidated C-terminal residue. Sequence comparison and phylogenetic clustering analysis classifies anuroctoxin into subfamily 6 of the alpha-KTx scorpion toxins (systematic name, alpha-KTx 6.12). Patch-clamp experiments show that anuroctoxin is a high-affinity blocker of Kv1.3 channels of human T lymphocytes with a K(d) of 0.73 nM, and it does not block the Ca(2+)-activated IKCa1 K(+) channels. These two channels play different but important roles in T-lymphocyte activation. Furthermore, the toxin practically does not inhibit Shaker IR, mKv1.1, and rKv2.1 channels, whereas the affinity of anuroctoxin for hKv1.2 is almost an order of magnitude smaller than for Kv1.3. The pharmacological profile and the selectivity of this new toxin for Kv1.3 over IKCa1 may provide an important tool for the modulation of the immune system, especially in cases in which selective inhibition of Kv1.3 is required.


Subject(s)
Potassium Channel Blockers/isolation & purification , Potassium Channels, Calcium-Activated/antagonists & inhibitors , Potassium Channels, Voltage-Gated/antagonists & inhibitors , Scorpion Venoms/analysis , T-Lymphocytes/drug effects , Toxins, Biological/isolation & purification , Animals , Humans , Intermediate-Conductance Calcium-Activated Potassium Channels , Kv1.3 Potassium Channel , Models, Molecular , Phylogeny , Potassium Channel Blockers/chemistry , Potassium Channel Blockers/pharmacology , Sequence Alignment , Toxins, Biological/chemistry , Toxins, Biological/pharmacology
12.
Biochimie ; 86(6): 387-96, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15358055

ABSTRACT

Current literature concerning the taxonomic names of two possibly distinct species of scorpions from the genus Centruroides (sculpturatus and/or exilicauda) is controversial. This communication reports the results of biochemical, genetic and electrophysiological experiments conducted with C. exilicauda Wood of Baja California (Mexico) and C. sculpturatus Ewing of Arizona (USA). The chromatographic profile fractionation of the soluble venom from both species of scorpions is different. The N-terminal amino acid sequence for nine toxins of C. exilicauda was determined and compared with those from C. sculpturatus. Lethality tests conducted in mice support the idea that C. exilicauda venom should be expected to be medically less important than C. sculpturatus. Thirteen genes from the venomous glands of the scorpion C. exilicauda were obtained and compared with previously published sequences from genes of the species C. sculpturatus. Genes coding for cytochrome oxidase I and II of both species were also sequenced. A phylogenetic tree was generated with this information showing important differences between them. Additionally, the results of electrophysiological assays conducted with the venom from both species on the Ca(2+)-dependent K(+)-channels, showed significant differences. These results strongly support the conclusion that C. exilicauda and C. sculpturatus are in fact two distinct species of scorpions.


Subject(s)
Scorpion Venoms/genetics , Scorpion Venoms/toxicity , Scorpions/physiology , Amino Acid Sequence , Animals , Arizona , Cloning, Molecular , DNA, Mitochondrial/genetics , Electron Transport Complex IV/genetics , Electron Transport Complex IV/metabolism , Electrophysiology/methods , Female , Mexico , Mice , Mice, Inbred Strains , Molecular Sequence Data , Phylogeny , Protein Subunits , Scorpion Venoms/chemistry , Scorpions/classification , Sequence Analysis , Sequence Homology, Amino Acid , Sodium Channels/drug effects , Species Specificity , Toxins, Biological/chemistry , Toxins, Biological/isolation & purification
13.
Hybrid Hybridomics ; 22(1): 23-31, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12713687

ABSTRACT

Dendritic cells (DC) are the professional antigen-presenting cells of the immune system. Previous studies have demonstrated that targeting foreign antigens to DC leads to enhanced antigen (Ag)-specific responses in vivo. However, the utility of this strategy for the generation of MAbs has not been investigated. To address this question we immunized mice with IgG-peptide conjugates prepared with the hamster anti-murine CD11c MAb N418. Synthetic peptides corresponding to two different exposed regions of DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN), a human C-type lectin, were conjugated to N418 using thiol-based chemistry. The N418 MAb served as the targeting molecule and synthetic peptides as the Ag (MAb-Ag). A rapid and peptide specific serum IgG response was produced by Day 7 when the synthetic peptides were linked to the N418 MAb, compared to peptide co-delivered with the N418 without linkage. Spleen cells from N418-peptide immunized mice were fused on Day 10, and three IgG1/k monoclonal antibodies (MAbs) were selected to one of the peptide epitopes (MID-peptide). One of the MAbs, Novik 2, bound to two forms of recombinant DC-SIGN protein in enzyme-linked immunosorbent assay (ELISA), and was specifically inhibited by the MID-peptide in solution. Two of these MAbs show specific binding to DC-SIGN expressed by cultured human primary DC. We conclude that in vivo DC targeting enhances the immunogenicity of synthetic peptides and is an effective method for the rapid generation of MAbs to predetermined epitopes.


Subject(s)
Antibodies, Monoclonal/immunology , Dendritic Cells/immunology , Animals , Antibodies, Monoclonal/metabolism , CD11c Antigen/immunology , Cell Adhesion Molecules/analysis , Cell Adhesion Molecules/immunology , Flow Cytometry , Humans , Lectins, C-Type/analysis , Lectins, C-Type/immunology , Mice , Peptides/metabolism , Receptors, Cell Surface/analysis , Receptors, Cell Surface/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...